Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study

European Heart Journal

Volumn 29, Issue 11, 2008, Pages 1350-1358

  Ciszewski, Andrzej ^a   Bilinska, Zofia T ^a   Brydak, Lidia B ^b,c   Kepka, Cezary ^a   Kruk, Mariusz ^a   Romanowska, Magdalena ^b   Ksiezycka, Ewa ^a   Przyluski, Jakub ^a   Piotrowski, Walerian ^a   Maczynska, Renata ^a   Ruzyllo, Witold ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Coronary disease; Infection; Influenza; Prevention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIBODY; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; PLACEBO; STATIN; THIENOPYRIDINE DERIVATIVE; TRIACYLGLYCEROL; VIRUS ANTIGEN;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE DRUG REACTION; AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ANTIGEN ANTIBODY REACTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLUENZA; INFLUENZA VACCINATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS; VACCINATION REACTION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 44949133987     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm581     Document Type: Article

References (29)

1. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemic. Public Health Rep 1932;47:2159-2179.
2. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981;101:512-513.
3. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infarction or vaccination. N Eng J Med 2004;351:2611-2618.
4. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984;53:481-482.
5. Jakovljevic D, Salomaa V, Sivenius J, Tamminen M, Sarti C, Salmi K, Kaarsalo E, Narva V, Immonen-Raiha P, Torppa J, Tuomilehto J. Seasonal variation in the occurrence of stroke in a Finnish adult population: The FINMONICA Stroke Register. Finnish Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1996;27:1774-1779.
6. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Eng J Med 1976;295:369-377.
7. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells SW. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years autopsies in 34 892 subjects. Eur Heart J 2007;28:1205-1210.
8. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-3045.
9. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. [Erratum Stroke 2002;33, 1171] Stroke 2002;33:513- 518.
10. Siscovick DS, Raghunathan TE, Lin D, Weinmann S, Arbogast P, Lemaitre RN, Psaty BM, Alexander R, Cobb LA. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000;152:674-677.
11. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004;25:25-31.
12. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, Stott DJ. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet 2000;355:93-97.
13. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002;105:2143-2147.
14. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006;47:2130-2139.
15. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-1140.
16. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-1381.
17. The European Agency for the Evaluation of Medicinal Products. EU recommendations for the influenza vaccine composition for the season 2004/2005. London. http://www.emea.eu.int/pdfs/human/bwp/110404en.pdf. (2 March 2004).
18. European Influenza Surveillance Scheme. Annual report, 2004-2005 influenza season, Utrecht, the Netherlands, NIVEL, 2006, 1-61.
19. Lusis A, Fogelman AM, Fonarow GC. Genetic Basis of Atherosclerosis: part II. Clinical Implications. Circulation 2004;110:2066-2071.
20. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226- 232.
21. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, Van de Werf F, Wallentin L, Behar S. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-2293.
22. Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, Thompson WW, Vaccine Safety Datalink Study Group Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002;156:634-640.
23. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation 2001;103:2283-2288.
24. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM. Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide. Circulation 2002;106:1127- 1132.
25. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-defficient mice. Circulation 2003;107:762-768.
26. Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003;108:2730-2736.
27. Gurevich VS. Influenza, autoimmunity and atherosclerosis. Autoimmun Rev 2005;4:101-105.
28. Azambuja MI, Duncan BB. Similarities in mortality patterns from influenza in the first half of the 20th century and the rise and fall of ischemic heart disease in the United States: a new hypothesis concerning the coronary heart disease epidemic. Cad Saude Publica 2002;18:557-577.
29. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infect Dis 2006;43:199-205.